​

Guardant Health (GH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

GH Stock Forecast

Guardant Health (GH) stock forecast, based on 30 Wall Street analysts, predicts a 12-month average price target of $120.00, with a high of $155.00 and a low of $75.00. This represents a 4.58% increase from the last price of $114.74.

- $40 $80 $120 $160 $200 High: $155 Avg: $120 Low: $75 Last Closed Price: $114.74

GH Stock Rating

Guardant Health stock's rating consensus is Buy, based on 30 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 28 Buy (93.33%), 1 Hold (3.33%), 1 Sell (3.33%), and 0 Strong Sell (0.00%).

Buy
Total 30 1 1 28 Strong Sell Sell Hold Buy Strong Buy

GH Price Target Upside V Benchmarks

TypeNameUpside
StockGuardant Health4.58%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks6.54%

Price Target Trends

1M3M12M
# Anlaysts51726
Avg Price Target$122.00$118.53$102.69
Last Closing Price$114.74$114.74$114.74
Upside/Downside6.33%3.30%-10.50%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26517--123
Dec, 25517-1-23
Nov, 25517--123
Oct, 25518--124
Sep, 255161-123
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 26, 2026Guggenheim$135.00$115.6916.69%17.66%
Jan 09, 2026Stifel Nicolaus$120.00$108.7410.35%4.58%
Jan 09, 2026Mizuho Securities$135.00$108.7424.15%17.66%
Jan 05, 2026Subbu NambiGuggenheim$115.00$99.0016.16%0.23%
Jan 05, 2026Vijay KumarEvercore ISI$105.00$101.743.20%-8.49%
Dec 22, 2025Canaccord Genuity$125.00$99.7425.33%8.94%
Dec 17, 2025Mizuho Securities$120.00$100.0020.00%4.58%
Dec 15, 2025Leerink Partners$155.00$104.0049.04%35.09%
Dec 15, 2025Brandon CouillardWells Fargo$120.00$102.0417.60%4.58%
Dec 15, 2025Barclays$120.00$102.0417.60%4.58%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 26, 2026GuggenheimBuyBuyhold
Jan 07, 2026Cowen & Co.BuyBuyhold
Jan 05, 2026GuggenheimBuyBuyhold
Dec 15, 2025Wells FargoOverweightOverweighthold
Dec 15, 2025BarclaysOverweightOverweighthold
Dec 12, 2025BTIGBuyBuyhold
Dec 11, 2025CitigroupBuyBuyhold
Oct 30, 2025Cowen & Co.BuyBuyhold
Oct 30, 2025UBSBuyBuyhold
Oct 30, 2025CitigroupBuyBuyhold

Financial Forecast

EPS Forecast

$-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.80$-6.41$-4.28$-3.56----
Avg Forecast$-4.26$-6.45$-3.58$-3.41$-2.90$-2.46$-2.32$-2.13
High Forecast$-4.11$-6.26$-3.49$-3.32$-2.26$-1.18$-0.24$-2.04
Low Forecast$-4.36$-6.80$-3.68$-3.50$-3.73$-2.99$-3.72$-2.29
Surprise %-10.80%-0.62%19.55%4.40%----

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$373.65M$449.54M$563.95M$739.02M----
Avg Forecast$364.29M$446.54M$558.07M$729.04M$846.27M$1.02B$1.23B$1.46B
High Forecast$370.66M$464.85M$589.10M$729.24M$868.09M$1.02B$1.24B$1.54B
Low Forecast$354.33M$435.97M$538.39M$728.83M$819.82M$1.02B$1.22B$1.41B
Surprise %2.57%0.67%1.05%1.37%----

Net Income Forecast

$-700M $-560M $-420M $-280M $-140M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-384.77M$-654.59M$-479.45M$-436.37M----
Avg Forecast$-372.37M$-508.71M$-479.45M$-382.22M$-364.59M$-312.67M$-168.64M$-238.87M
High Forecast$-297.90M$-406.97M$-383.56M$-372.11M$-252.82M$-132.14M$-27.21M$-227.92M
Low Forecast$-446.85M$-610.45M$-575.34M$-392.33M$-417.56M$-334.31M$-416.51M$-256.14M
Surprise %3.33%28.68%-14.17%----

GH Forecast FAQ

Is Guardant Health stock a buy?

Guardant Health stock has a consensus rating of Buy, based on 30 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 28 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Guardant Health is a favorable investment for most analysts.

What is Guardant Health's price target?

Guardant Health's price target, set by 30 Wall Street analysts, averages $120 over the next 12 months. The price target range spans from $75 at the low end to $155 at the high end, suggesting a potential 4.58% change from the previous closing price of $114.74.

How does Guardant Health stock forecast compare to its benchmarks?

Guardant Health's stock forecast shows a 4.58% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the diagnostics & research stocks industry (6.54%).

What is the breakdown of analyst ratings for Guardant Health over the past three months?

  • January 2026: 21.74% Strong Buy, 73.91% Buy, 0% Hold, 0% Sell, 4.35% Strong Sell.
  • December 2025: 21.74% Strong Buy, 73.91% Buy, 0% Hold, 4.35% Sell, 0% Strong Sell.
  • November 2025: 21.74% Strong Buy, 73.91% Buy, 0% Hold, 0% Sell, 4.35% Strong Sell.

What is Guardant Health’s EPS forecast?

Guardant Health's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.9, marking a -18.54% decrease from the reported $-3.56 in 2024. Estimates for the following years are $-2.46 in 2026, $-2.32 in 2027, and $-2.13 in 2028.

What is Guardant Health’s revenue forecast?

Guardant Health's average annual revenue forecast for its fiscal year ending in December 2025 is $846.27M, reflecting a 14.51% increase from the reported $739.02M in 2024. The forecast for 2026 is $1.02B, followed by $1.23B for 2027, and $1.46B for 2028.

What is Guardant Health’s net income forecast?

Guardant Health's net income forecast for the fiscal year ending in December 2025 stands at $-365M, representing a -16.45% decrease from the reported $-436M in 2024. Projections indicate $-313M in 2026, $-169M in 2027, and $-239M in 2028.